Company Profile
Theseus Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- THRX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for THRX.
Company overview
Business overview
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy. The company aims to build differentiated assets in genetically defined tumors.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Theseus sits in specialty oncology biotechnology.
Business Model Characteristics
The business depends on clinical proof, target selectivity, and the ability to create a focused oncology franchise.
Position Within the Biotechnology Landscape
Theseus is a small-cap oncology catalyst name where early data can materially reshape the story.
Future catalysts
Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward. The company still needs a clearer development road map.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK
GSK · Source: GSK plc
- 02
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
LEGN · Source: Legend Biotech Corporation
- 03
- 04
- 05
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Theseus Pharmaceuticals do?
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy. The company aims to build differentiated assets in genetically defined tumors.
On which exchange is THRX stock listed?
Theseus Pharmaceuticals (THRX) is associated with NASDAQ, United States, Biopharma.
What is Theseus?
Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward.
Which conditions is Theseus Pharmaceuticals targeting with Theseus?
Theseus Pharmaceuticals is associated with oncology, cancer therapeutics, genetic disease based on its company overview and current catalyst commentary.
How does Theseus Pharmaceuticals describe recent progress with Theseus?
Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward.
What is Pharmaceuticals?
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy.
What should investors watch for with Pharmaceuticals?
Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward.
What future catalysts are investors watching for Theseus Pharmaceuticals?
Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward. The company still needs a clearer development road map.